NASDAQ · VMDHealthcareHealth Services

Viemed Healthcare financials

$9.23+1.32%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
FY21
Dec 31
FY20
Dec 31
FY19
Dec 31
Revenue$270.3M$224.3M$183.0M$138.8M$117.1M$131.3M$80.3M
Gross profit$155.5M$133.2M$112.8M$84.7M$73.4M$80.1M$56.0M
Gross margin57.5%59.4%61.6%61.0%62.7%61.0%69.8%
Operating income$20.5M$16.2M$14.9M$7.6M$10.4M$20.5M$9.2M
Net income$14.9M$11.3M$10.2M$6.2M$9.1M$31.5M$8.5M
Net margin5.5%5.0%5.6%4.5%7.8%24.0%10.6%
Diluted EPS$0.37$0.28$0.25$0.16$0.22$0.78$0.21
EBITDA$49.1M$41.5M$36.7M$23.2M$21.7M$30.1M$15.6M
Operating cash flow$51.9M$39.1M$45.2M$27.7M$22.5M$35.1M$19.1M
Free cash flow$11.9M$318.0K$19.1M$4.7M$2.2M$21.4M$5.7M
Diluted shares40.8M40.8M40.4M39.8M40.7M40.5M39.7M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31Dec 31Dec 31
Cash & equivalents$13.5M$17.5M$12.8M$16.9M$28.4M$31.0M
Short-term investments$0.00$0.00$0.00$0.00——
Total debt$12.4M$4.0M$7.5M$0.00$5.8M$7.6M
Total assets$199.2M$177.1M$154.9M$117.0M$118.0M$112.6M
Total liabilities$55.6M$43.8M$41.0M$19.9M$23.1M$30.9M
Shareholders' equity$143.5M$133.3M$113.9M$97.1M$94.8M$81.7M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology